GILD

Profit From Volatility in Gilead and Celgene

The stocks popped Monday on good drug trials -- but these stocks should be on your radar for regular income through selling overheated puts. More

Get the scoop on today's big moves. See which stock hit a new 52-week high, and one that found a new 52-week low. More

Wall Street saw three big deals in the mergers & acquisition world Monday, but the markets mostly shrugged with a flat performance. More

ETFs should offer diversified exposure, but what happens when one or two stocks are running the whole show? It happens more than you think. More

Amgen, Gilead Science and Questcor Pharmaceuticals posted third-quarter earnings and revenue that beat Wall Street forecasts. More

Stay on top of earnings news with this daily roundup of the biggest names reporting. Here are today's noteworthy headlines. More

Rather than stock-picking to profit off today's major trends, investors can improve their chances by buying into these mutual funds and ETFs. More